Category: Drug Recall Notices
-
Trulicity Recall Due to Dose Labeling Error Back in 2021 May Still be Drug Safety Issue Today
Thousands of Trulicity Autoinjector Devices Labeled as 0.75 mg Might Contain 1.5 mg (i.e., a “double-dose”) (Posted by Tom Lamb at Drug Injury Watch) A Trulicity recall back in August – September 2021 by Eli…
-
February Recalls of Eye Products Due to Bacterial Contamination Causing Serious Infections
Timeline for EzriCare Artificial Tears, Delsam Pharma’s Artificial Tears, Delsam Pharma’s Artificial Eye Ointment (Posted by Tom Lamb at Drug Injury Watch) During February 2023 there were recalls of Global Pharma eye products, specifically: EzriCare…
-
Delsam Pharma’s Artificial Eye Ointment Recalled, Weeks After Artificial Tears Products Withdrawal
Updates About Bacterial Contamination Problem for These Over-The-Counter (OTC) Eye Products Given by FDA and CDC (Posted by Tom Lamb at Drug Injury Watch) On February 21, 2023, and February 22, 2023, there were updates…
-
Artificial Tears Eye Drops Recall Involving EzriCare and Delsam Pharma’s Products in February 2023
Serious Infections Causing Vision Loss Have Been Linked to the Use of EzriCare Artificial Tears Lubricant Eye Drops (Posted by Tom Lamb at Drug Injury Watch) Today we pick up where our article from last…
-
New FDA Regulatory Action for Ukoniq Recall First Announced by Drug Company in April 2022
June 2022 FDA Drug Safety Communication Makes Clear That Ukoniq Was Removed From Market Due to Safety Issues (Posted by Tom Lamb at Drug Injury Watch) On June 1, 2022, the FDA issued an update…
-
Ukoniq Drug Recall in April 2022 Comes Soon After FDA Warning About Increased Risk of Death in February 2022
This "New" Lymphoma Drug Had Only Been on the Market Since February 2021, When Ukoniq Received FDA Accelerated Approval (Posted by Tom Lamb at Drug Injury Watch) In February 2022 we wrote about this Drug…
-
Picato Recalls Continue with Canada and Denmark Being Most Recent, All Due to Risk of Skin Cancer
A Global Phase-out of Picato Sales by LEO Pharma Inc. Due to this Picato Safety Finding Expected by End of 2020 (Posted by Tom Lamb at DrugInjuryWatch.com) But first, we get…
-
Report on FDA Belviq Recall Decision Provides New Information About Excess Cancers Risks
Belviq Safety Data Review Found Higher Rates of Colorectal Cancer, Pancreatic Cancer, and Lung Cancer (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA's decision to request that the pharmaceutical company Eisai recall…
-
Zantac Recall In April 2020 Comes 7 Months After The Zantac FDA Warning In September 2019
Level Of Chemical NDMA In Zantac Pills Can Cause Cancers: Pancreatic, Stomach, Colon, Rectal, Bladder, Kidney (Posted by Tom Lamb at DrugInjuryWatch.com) On April 1, 2020, the FDA announced that it was…